BERNS PAUL L

13D and 13G Filings

13D/G filings
13G on 1 security
CIK
0001202769
All SEC filings
View on sec.gov
Issuer % of Class Filed
Neumora Therapeutics, Inc. 13G/A Amendment 2
NMRA · 640979100
5.4% 11/16/2026
Event 9/30/2026
Neumora Therapeutics, Inc. 13G/A Amendment 1
NMRA · 640979100
5.1% 2/13/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.